{"nctId":"NCT01763827","briefTitle":"Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2","startDateStruct":{"date":"2013-01-21","type":"ACTUAL"},"conditions":["Hyperlipidemia"],"count":615,"armGroups":[{"label":"Placebo Q2W","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo to Evolocumab","Other: Placebo to Ezetimibe"]},{"label":"Placebo QM","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo to Evolocumab","Other: Placebo to Ezetimibe"]},{"label":"Ezetimibe (Q2W)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ezetimibe","Biological: Placebo to Evolocumab"]},{"label":"Ezetimibe (QM)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ezetimibe","Biological: Placebo to Evolocumab"]},{"label":"Evolocumab Q2W","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Other: Placebo to Ezetimibe"]},{"label":"Evolocumab QM","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Other: Placebo to Ezetimibe"]}],"interventions":[{"name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"name":"Ezetimibe","otherNames":["Zetia"]},{"name":"Placebo to Evolocumab","otherNames":[]},{"name":"Placebo to Ezetimibe","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female ≥ 18 to ≤ 80 years of age\n* National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) Framingham risk score of 10% or less\n* Fasting LDL-C ≥ 100 mg/dL (2.6 mmol/L) and \\<190 mg/dL\n* Fasting triglycerides ≤ 400 mg/dL (4.5 mmol/L)\n\nExclusion Criteria:\n\n* History of coronary heart disease\n* New York Heart Association (NYHA) III or IV heart failure\n* Uncontrolled cardiac arrhythmia\n* Uncontrolled hypertension\n* Diabetes mellitus (Type 1 diabetes, poorly controlled type 2 diabetes)\n* Uncontrolled hypothyroidism or hyperthyroidism","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.10","spread":"1.67"},{"groupId":"OG001","value":"-1.34","spread":"1.54"},{"groupId":"OG002","value":"-17.75","spread":"1.67"},{"groupId":"OG003","value":"-18.57","spread":"1.56"},{"groupId":"OG004","value":"-57.04","spread":"1.23"},{"groupId":"OG005","value":"-56.12","spread":"1.12"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"1.45"},{"groupId":"OG001","value":"-1.41","spread":"1.37"},{"groupId":"OG002","value":"-17.52","spread":"1.46"},{"groupId":"OG003","value":"-19.12","spread":"1.39"},{"groupId":"OG004","value":"-56.93","spread":"1.07"},{"groupId":"OG005","value":"-58.81","spread":"1.00"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"2.3"},{"groupId":"OG001","value":"0.0","spread":"2.1"},{"groupId":"OG002","value":"-23.1","spread":"2.3"},{"groupId":"OG003","value":"-25.9","spread":"2.1"},{"groupId":"OG004","value":"-78.4","spread":"1.7"},{"groupId":"OG005","value":"-81.9","spread":"1.5"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"2.5"},{"groupId":"OG001","value":"-0.1","spread":"2.4"},{"groupId":"OG002","value":"-23.4","spread":"2.5"},{"groupId":"OG003","value":"-25.0","spread":"2.4"},{"groupId":"OG004","value":"-78.4","spread":"1.9"},{"groupId":"OG005","value":"-77.9","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Achieved a Mean LDL-C at Weeks 10 and 12 of Less Than 70 mg/dL","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"1.3","spread":null},{"groupId":"OG003","value":"2.8","spread":null},{"groupId":"OG004","value":"73.6","spread":null},{"groupId":"OG005","value":"71.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Achieved LDL-C < 70 mg/dL at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"1.4","spread":null},{"groupId":"OG003","value":"1.4","spread":null},{"groupId":"OG004","value":"72.9","spread":null},{"groupId":"OG005","value":"65.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.41","spread":"1.34"},{"groupId":"OG001","value":"1.32","spread":"1.24"},{"groupId":"OG002","value":"-14.64","spread":"1.35"},{"groupId":"OG003","value":"-16.48","spread":"1.25"},{"groupId":"OG004","value":"-50.22","spread":"0.99"},{"groupId":"OG005","value":"-51.96","spread":"0.90"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.31","spread":"1.48"},{"groupId":"OG001","value":"1.51","spread":"1.38"},{"groupId":"OG002","value":"-14.89","spread":"1.47"},{"groupId":"OG003","value":"-16.48","spread":"1.39"},{"groupId":"OG004","value":"-50.12","spread":"1.08"},{"groupId":"OG005","value":"-49.68","spread":"1.01"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"1.51"},{"groupId":"OG001","value":"1.54","spread":"1.41"},{"groupId":"OG002","value":"-13.47","spread":"1.52"},{"groupId":"OG003","value":"-14.75","spread":"1.43"},{"groupId":"OG004","value":"-47.04","spread":"1.12"},{"groupId":"OG005","value":"-49.39","spread":"1.03"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.59","spread":"1.58"},{"groupId":"OG001","value":"1.84","spread":"1.53"},{"groupId":"OG002","value":"-13.17","spread":"1.58"},{"groupId":"OG003","value":"-14.02","spread":"1.54"},{"groupId":"OG004","value":"-47.21","spread":"1.17"},{"groupId":"OG005","value":"-46.59","spread":"1.12"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/High Density Lipoprotein-cholesterol Ratio at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.44","spread":"1.29"},{"groupId":"OG001","value":"6.42","spread":"1.50"},{"groupId":"OG002","value":"-9.14","spread":"1.29"},{"groupId":"OG003","value":"-11.90","spread":"1.51"},{"groupId":"OG004","value":"-38.49","spread":"0.95"},{"groupId":"OG005","value":"-39.41","spread":"1.08"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/High Density Lipoprotein-cholesterol Ratio at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.18","spread":"1.39"},{"groupId":"OG001","value":"7.02","spread":"1.67"},{"groupId":"OG002","value":"-10.03","spread":"1.39"},{"groupId":"OG003","value":"-12.34","spread":"1.68"},{"groupId":"OG004","value":"-38.45","spread":"1.02"},{"groupId":"OG005","value":"-37.65","spread":"1.21"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.01","spread":"1.69"},{"groupId":"OG001","value":"3.85","spread":"1.77"},{"groupId":"OG002","value":"-13.39","spread":"1.69"},{"groupId":"OG003","value":"-14.49","spread":"1.79"},{"groupId":"OG004","value":"-48.12","spread":"1.25"},{"groupId":"OG005","value":"-51.10","spread":"1.29"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.12","spread":"1.77"},{"groupId":"OG001","value":"4.51","spread":"1.90"},{"groupId":"OG002","value":"-12.69","spread":"1.77"},{"groupId":"OG003","value":"-14.29","spread":"1.92"},{"groupId":"OG004","value":"-48.45","spread":"1.31"},{"groupId":"OG005","value":"-48.26","spread":"1.39"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein (a) at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"2.72"},{"groupId":"OG001","value":"0.00","spread":"2.96"},{"groupId":"OG002","value":"0.00","spread":"2.72"},{"groupId":"OG003","value":"-2.08","spread":"3.01"},{"groupId":"OG004","value":"-18.37","spread":"2.02"},{"groupId":"OG005","value":"-19.24","spread":"2.17"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein (a) at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"2.75"},{"groupId":"OG001","value":"0.00","spread":"3.26"},{"groupId":"OG002","value":"0.00","spread":"2.75"},{"groupId":"OG003","value":"-2.05","spread":"3.28"},{"groupId":"OG004","value":"-20.41","spread":"2.04"},{"groupId":"OG005","value":"-17.82","spread":"2.39"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.89","spread":"3.64"},{"groupId":"OG001","value":"4.89","spread":"4.02"},{"groupId":"OG002","value":"-1.46","spread":"3.60"},{"groupId":"OG003","value":"-3.97","spread":"4.04"},{"groupId":"OG004","value":"-9.16","spread":"2.65"},{"groupId":"OG005","value":"-15.71","spread":"2.92"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.91","spread":"3.13"},{"groupId":"OG001","value":"2.01","spread":"3.86"},{"groupId":"OG002","value":"0.00","spread":"3.15"},{"groupId":"OG003","value":"-2.41","spread":"3.89"},{"groupId":"OG004","value":"-8.14","spread":"2.31"},{"groupId":"OG005","value":"-15.64","spread":"2.78"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Very Low Density Lipoprotein Cholesterol (VLDL-C) at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.81","spread":"3.09"},{"groupId":"OG001","value":"4.22","spread":"3.70"},{"groupId":"OG002","value":"-2.69","spread":"3.12"},{"groupId":"OG003","value":"-3.33","spread":"3.69"},{"groupId":"OG004","value":"-8.40","spread":"2.28"},{"groupId":"OG005","value":"-16.17","spread":"2.65"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in VLDL-C at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.58","spread":"3.67"},{"groupId":"OG001","value":"0.00","spread":"3.93"},{"groupId":"OG002","value":"-0.94","spread":"3.65"},{"groupId":"OG003","value":"-3.61","spread":"3.87"},{"groupId":"OG004","value":"-9.52","spread":"2.64"},{"groupId":"OG005","value":"-16.33","spread":"2.80"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in High-density Lipoprotein Cholesterol (HDL-C) at the Mean of Weeks 10 and 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.64","spread":"1.26"},{"groupId":"OG001","value":"-4.67","spread":"1.32"},{"groupId":"OG002","value":"-0.92","spread":"1.27"},{"groupId":"OG003","value":"0.00","spread":"1.33"},{"groupId":"OG004","value":"3.89","spread":"0.93"},{"groupId":"OG005","value":"3.81","spread":"0.95"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in HDL-C at Week 12","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.15","spread":"1.43"},{"groupId":"OG001","value":"-5.27","spread":"1.40"},{"groupId":"OG002","value":"-2.79","spread":"1.42"},{"groupId":"OG003","value":"-1.47","spread":"1.41"},{"groupId":"OG004","value":"4.76","spread":"1.05"},{"groupId":"OG005","value":"4.06","spread":"1.01"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":76},"commonTop":["Headache","Diarrhoea","Nasopharyngitis"]}}}